MYOM1

Chr 18

myomesin 1

Also known as: SKELEMIN

Myomesin 1 is a major component of the sarcomere M band that binds myosin, titin, and light meromyosin to maintain muscle fiber structure. Mutations cause autosomal recessive myopathy with rigidity of extraocular muscles and nocardiosis susceptibility, as well as hypertrophic cardiomyopathy. This gene is not highly constrained against loss-of-function variants and primarily affects skeletal and cardiac muscle systems.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
6
Pubs (1 yr)
4
P/LP submissions
0%
P/LP missense
0.95
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryMYOM1
🧬
Gene-Disease Validity (ClinGen)
hypertrophic cardiomyopathy · ADDisputed

Disputed — evidence questions this relationship

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
4 unique Pathogenic / Likely Pathogenic· 378 VUS of 600 total submissions
📖
GeneReview available — MYOM1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.95LOEUF
pLI 0.000
Z-score 1.93
OE 0.78 (0.650.95)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.62Z-score
OE missense 0.94 (0.891.00)
920 obs / 974.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.78 (0.650.95)
00.351.4
Missense OE0.94 (0.891.00)
00.61.4
Synonymous OE1.00
01.21.6
LoF obs/exp: 73 / 93.1Missense obs/exp: 920 / 974.3Syn Z: -0.02
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedMYOM1-related hypertrophic cardiomyopathyOTHERAD
DN
0.6745th %ile
GOF
0.6930th %ile
LOF
0.4627th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

600 submitted variants in ClinVar

Classification Summary

Pathogenic3
Likely Pathogenic1
VUS378
Likely Benign197
Benign2
3
Pathogenic
1
Likely Pathogenic
378
VUS
197
Likely Benign
2
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
3
0
3
Likely Pathogenic
0
0
1
0
1
VUS
15
326
33
4
378
Likely Benign
0
4
80
113
197
Benign
0
0
2
0
2
Total15330119117581

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

MYOM1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found